| Glycans as key checkpoints of T cell activity and function MS Pereira, I Alves, M Vicente, A Campar, MC Silva, NA Padrao, V Pinto, ... Frontiers in immunology 9, 2754, 2018 | 140 | 2018 |
| Composition of the immunoglobulin G glycome associates with the severity of COVID-19 T Petrović, I Alves, D Bugada, J Pascual, F Vučković, A Skelin, J Gaifem, ... Glycobiology 31 (4), 372-377, 2021 | 43 | 2021 |
| Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity MM Vicente, I Alves, J Gaifem, CS Rodrigues, Â Fernandes, AM Dias, ... European journal of immunology 52 (6), 946-957, 2022 | 32 | 2022 |
| Glycans as shapers of tumour microenvironment: a sweet driver of T‐cell‐mediated anti‐tumour immune response A Fernandes, CM Azevedo, MC Silva, G Faria, CS Dantas, MM Vicente, ... Immunology 168 (2), 217-232, 2023 | 20 | 2023 |
| Protein mannosylation as a diagnostic and prognostic biomarker of lupus nephritis: an unusual glycan neoepitope in systemic lupus erythematosus I Alves, B Santos‐Pereira, H Dalebout, S Santos, MM Vicente, A Campar, ... Arthritis & rheumatology 73 (11), 2069-2077, 2021 | 20 | 2021 |
| The off-targets of CRISPR gene editing MM Vicente, M Chaves-Ferreira, JMP Jorge, J Proença, VM Barreto Frontiers in Cell and Developmental Biology, 2392, 0 | 19* | |
| Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity MM Vicente, I Alves, Â Fernandes, AM Dias, B Santos-Pereira, ... Cellular & Molecular Immunology 20 (8), 955-968, 2023 | 11 | 2023 |
| Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications MM Vicente, E Leite-Gomes, SS Pinho Trends in Immunology, 2023 | 8 | 2023 |
| SARS-CoV-2 infection drives a glycan switch of peripheral T cells at diagnosis I Alves, MM Vicente, J Gaifem, A Fernandes, AM Dias, CS Rodrigues, ... The Journal of Immunology 207 (6), 1591-1598, 2021 | 7 | 2021 |
| The role of glycosylation in inflammatory diseases I Alves, MM Vicente, AM Dias, J Gaifem, C Rodrigues, A Campar, ... The Role of Glycosylation in Health and Disease, 265-283, 2021 | 7 | 2021 |
| A CyclinB2-Cas9 fusion promotes the homology-directed repair of double-strand breaks MM Vicente, A Mendes, M Cruz, JR Vicente, VM Barreto bioRxiv, 555144, 2019 | 2 | 2019 |
| AB1368 UNRAVELLING THE (T) REGULATORY POWER OF GLYCANS IN MYASTHENIA GRAVIS: MECHANISM AND POTENTIAL CLINICAL APPLICATIONS Â Fernandes, MM Vicente, P Carneiro, MI Leite, ME Santos, S Pinho Annals of the Rheumatic Diseases 83 (Suppl 1), 2035-2036, 2024 | | 2024 |
| Cholangiocyte glycocalyx degradation boosts primary sclerosing cholangitis F Klein, F Wellhoener, A Freise, KM Niculovic, H Junca, M Vicente, E Katz, ... medRxiv, 2024.06. 27.24309484, 2024 | | 2024 |
| Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer IB Moreira, C Rossdam, J Beimdiek, MM Vicente, J Schmitz, A Oberbeck, ... bioRxiv, 2023.08. 08.552442, 2023 | | 2023 |
| Glycans as central regulators of the immunological pathways at the frontiers of microbial infections, chronic inflammation and autoimmunity. M Vicente, I Alves, A Fernandes, G Rabinovich, A Sousa, SS Pinho GLYCOBIOLOGY 32 (11), 965-966, 2022 | | 2022 |
| N-glycans mannosylation controls T-cell development by reprogramming thymocyte commitment, fate and repertoire MM Vicente, I Alves, Â Fernandes, AM Dias, E Pérez-Anton, A Correia, ... medRxiv, 2022.02. 04.22270265, 2022 | | 2022 |
| Glycans in cancer immunoediting: Glycosylated neoantigens as target for cancer immunotherapy M Silva, D Ruano, M Vicente, Bulk Van den, Jitske, Miranda de, Noel FCC, ... GLYCOBIOLOGY 31 (12), 1685-1685, 2021 | | 2021 |
| An unusual glycan-neoepitope with diagnostic and prognostic value in Systemic Lupus Erythematosus I Alves, B Santos-Pereira, H Dalebout, M Vicente, A Campar, S Santos, ... GLYCOBIOLOGY 30 (12), 1033-1033, 2020 | | 2020 |
